In addition, our study showed that UBE2C was significantly relevant to TME in many cancer types and the TME played a crucial role in tumor initiation, progression, and metastasis process and also threw light on therapeutic efficacy [44] suggesting that UBE2C might a potential immunotherapeutic target. Here, UBE2C is linked to cancer.